A novel single-chain antibody fragment for detection of mannose 6-phosphate-containing proteins: application in mucolipidosis type II patients and mice.
暂无分享,去创建一个
[1] A. Chabli,et al. [Enzyme replacement therapy for lysosomal storage disorders]. , 2011, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[2] T. Braulke,et al. Glycosylation- and phosphorylation-dependent intracellular transport of lysosomal hydrolases , 2009, Biological chemistry.
[3] D. Sleat,et al. Proteomics of the lysosome. , 2009, Biochimica et biophysica acta.
[4] J. Bonifacino,et al. Sorting of lysosomal proteins. , 2009, Biochimica et biophysica acta.
[5] A. Ballabio,et al. Lysosomal disorders: from storage to cellular damage. , 2009, Biochimica et biophysica acta.
[6] K. Ozono,et al. Mucolipidosis II and III alpha/beta: mutation analysis of 40 Japanese patients showed genotype–phenotype correlation , 2009, Journal of Human Genetics.
[7] Jung‐Ja P. Kim,et al. Strategies for carbohydrate recognition by the mannose 6-phosphate receptors. , 2008, Glycobiology.
[8] D. Sleat,et al. Proteomics Analysis of Serum from Mutant Mice Reveals Lysosomal Proteins Selectively Transported by Each of the Two Mannose 6-Phosphate Receptors*S , 2008, Molecular & Cellular Proteomics.
[9] H. Mandel,et al. When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients. , 2006, Molecular genetics and metabolism.
[10] W. Canfield,et al. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. , 2006, American journal of human genetics.
[11] B. Roe,et al. The α- and β-subunits of the Human UDP-N-acetylglucosamine:Lysosomal Enzyme Phosphotransferase Are Encoded by a Single cDNA* , 2005, Journal of Biological Chemistry.
[12] C. Ki,et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc‐phosphotransferase α/β subunits in Korean patients with mucolipidosis type II or type IIIA , 2005, Human mutation.
[13] C. Ki,et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA. , 2005, Human mutation.
[14] B. Henrissat,et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. , 2005, Nature medicine.
[15] T. Braulke,et al. A novel mutation in UDP‐N‐acetylglucosamine‐1‐phosphotransferase gamma subunit (GNPTAG) in two siblings with mucolipidosis type III alters a used glycosylation site , 2004, Human mutation.
[16] Jung‐Ja P. Kim,et al. Structure of uPAR, plasminogen, and sugar‐binding sites of the 300 kDa mannose 6‐phosphate receptor , 2004, The EMBO journal.
[17] A. Toutain,et al. Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III , 2004, Journal of Medical Genetics.
[18] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[19] A. Hasilik,et al. A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells. , 2003, The Biochemical journal.
[20] J. Garin,et al. Proteomic analysis of human lysosomes: Application to monocytic and breast cancer cells , 2002, Proteomics.
[21] T. Braulke,et al. MDCK cells secrete neutral proteases cleaving insulin-like growth factor-binding protein-2 to -6. , 2001, American journal of physiology. Endocrinology and metabolism.
[22] B. Roe,et al. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC) , 2000, The Journal of clinical investigation.
[23] C R MacKenzie,et al. Quantitative analyses of binding affinity and specificity for glycolipid receptors by surface plasmon resonance. , 2000, Methods in enzymology.
[24] T. Dierks,et al. Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Lobel,et al. Biophysical and Biological Properties of Naturally Occurring High Molecular Weight Insulin-like Growth Factor II Variants* , 1997, The Journal of Biological Chemistry.
[26] C. MacKenzie,et al. Bacterial expression and secretion of various single-chain Fv genes encoding proteins specific for a Salmonella serotype B O-antigen. , 1991, The Journal of biological chemistry.
[27] K. von Figura,et al. Insulin-like growth factors I and II stimulate endocytosis but do not affect sorting of lysosomal enzymes in human fibroblasts. , 1990, The Journal of biological chemistry.
[28] S. Kornfeld,et al. Ligand interactions of the cation-dependent mannose 6-phosphate receptor. Comparison with the cation-independent mannose 6-phosphate receptor. , 1989, The Journal of biological chemistry.
[29] K. von Figura,et al. Is movement of mannose 6-phosphate-specific receptor triggered by binding of lysosomal enzymes? , 1987, The Journal of cell biology.
[30] A. Varki,et al. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity. , 1981, The Journal of clinical investigation.
[31] K. von Figura,et al. Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts. , 1981, Biochemical and biophysical research communications.
[32] V. McKusick,et al. Mucolipidosis III: clinical and laboratory findings. , 1975, Birth defects original article series.
[33] R. Schmickel,et al. Accumulation of 32S-mucopolysaccharides in cultured mucolipidosis cells. , 1975, Birth defects original article series.
[34] H. Wiedemann,et al. The genetic mucolipidoses. Diagnosis and differential diagnosis. , 1970, Humangenetik.